Detalles de la búsqueda
1.
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
J Immunol
; 187(7): 3840-53, 2011 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21880982
2.
Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.
J Gen Virol
; 93(Pt 12): 2606-2613, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22971818
3.
Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice.
Proc Natl Acad Sci U S A
; 106(9): 3420-5, 2009 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19223589
4.
Novel method of monitoring trace cytokines and activated STAT molecules in the paws of arthritic mice using multiplex bead technology.
BMC Immunol
; 11: 55, 2010 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21073728
5.
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE.
Int Immunopharmacol
; 12(1): 257-70, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22178195
6.
Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer.
Mol Cancer Ther
; 11(4): 984-93, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22334590
7.
Animal models of systemic lupus erythematosus (SLE) and ex vivo assay design for drug discovery.
Curr Protoc Pharmacol
; Chapter 5: Unit 5.60, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21935901
8.
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.
Arthritis Res Ther
; 13(2): R68, 2011 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21510883
Resultados
1 -
8
de 8
1
Próxima >
>>